Shingles vaccine candidate strongly immunogenic in a Phase 3 trial

被引：0
|
作者：
不详
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2017年 / 13卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1734 / 1734
页数：1
相关论文
共 50 条
  • [11] A norovirus vaccine candidate enters a Phase 2 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2216 - 2217
  • [12] A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial
    Durbin, Anna P.
    Whitehead, Stephen S.
    Shaffer, Donna
    Elwood, Dan
    Wanionek, Kimberli
    Thumar, Bhavin
    Blaney, Joseph E.
    Murphy, Brian R.
    Schmidt, Alexander C.
    PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (08):
  • [13] Early phase II trial of human rotavirus vaccine candidate RV3
    Barnes, GL
    Lund, JS
    Mitchell, SV
    De Bruyn, L
    Piggford, L
    Smith, AL
    Furmedge, J
    Masendycz, PJ
    Bugg, HC
    Bogdanovic-Sakran, N
    Carlin, JB
    Bishop, RF
    VACCINE, 2002, 20 (23-24) : 2950 - 2956
  • [14] Conversion of poorly immunogenic malaria repeat sequences into a highly immunogenic vaccine candidate
    Milich, DR
    Hughes, J
    Jones, J
    Sällberg, M
    Phillips, TR
    VACCINE, 2001, 20 (5-6) : 771 - 788
  • [15] Universal influenza vaccine candidate is tested in a Phase 2 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) : 1307 - 1307
  • [16] Chikungunya Fever vaccine candidate passes phase 1 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (03) : 536 - 536
  • [17] Chikungunya vaccine candidate advances to a Phase 2 clinical trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (11) : 2721 - 2721
  • [18] A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
    Martin, Julie E.
    Sullivan, Nancy J.
    Enama, Mary E.
    Gordon, Ingelise J.
    Roederer, Mario
    Koup, Richard A.
    Bailer, Robert T.
    Chakrabarti, Bimal K.
    Bailey, Michael A.
    Gomez, Phillip L.
    Andrews, Charla A.
    Moodie, Zoe
    Gu, Lin
    Stein, Judith A.
    Nabel, Gary J.
    Graham, Barney S.
    CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (11) : 1267 - 1277
  • [19] An Inactivated Ross River Virus Vaccine Is Well Tolerated and Immunogenic in an Adult Population in a Randomized Phase 3 Trial
    Wressnigg, Nina
    van der Velden, Maikel V. W.
    Portsmouth, Daniel
    Draxler, Wolfgang
    O'Rourke, Maria
    Richmond, Peter
    Hall, Stephen
    McBride, William J. H.
    Redfern, Andrew
    Aaskov, John
    Barrett, P. Noel
    Aichinger, Gerald
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (03) : 267 - 273
  • [20] Amid Paraguay Chikungunya Outbreak, Vaccine Candidate Safe, Immunogenic
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (02): : 111 - 111
12345